drugset / Trial / NCT06853327

Oral Ketorolac for IUD Pain Reduction

NCT06853327

Phase 2 Enrolling by invitation 108 enrolled University of North Carolina, Chapel Hill
RandomizedParallel-groupTriple-blindTreatment

Summary

To determine if oral ketorolac given at different timepoints prior to intrauterine device (IUD) insertion influences pain experienced during this procedure.

Timeline

Start
2025-05-23
Primary completion
2026-06-30
Completion
2026-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 20 mg Oral

Indications

No indication recorded.